Numerous studies have shown the positive role of IL‐1β in the progression of various cancers, including breast cancer, lung cancer, and hematological malignancies.46, 47, 48 Moreover, IL‐1β has been found to be the most relevant to GC development. Here, IL1B is linked to breast carcinoma.